Jeffrey Thomas  Elliott net worth and biography

Jeffrey Elliott Biography and Net Worth

Jeff Elliott has served as our Executive Vice President and Chief Operating Officer since April 2021, and our Chief Financial Officer since November 2016. He previously served as Vice President, Business Development and Strategy, from June 2016 to November 2016. Prior to joining Exact Sciences, Mr. Elliott was with Robert W. Baird & Co., where from June 2012 to June 2016 he was a Senior Research Analyst who covered diagnostics and life science tools companies. Earlier in his career, Mr. Elliott worked in a supply chain role for Walgreens and as a consultant at Cap Gemini Ernst & Young. Mr. Elliott holds a Bachelor of Business Administration from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the University of Chicago Booth School of Business. Mr. Elliott is a CFA charterholder.

What is Jeffrey Thomas Elliott's net worth?

The estimated net worth of Jeffrey Thomas Elliott is at least $643,407.05 as of March 1st, 2024. Mr. Elliott owns 10,933 shares of Exact Sciences stock worth more than $643,407 as of April 26th. This net worth approximation does not reflect any other assets that Mr. Elliott may own. Additionally, Mr. Elliott receives a salary of $518,130.00 as CFO at Exact Sciences. Learn More about Jeffrey Thomas Elliott's net worth.

How old is Jeffrey Thomas Elliott?

Mr. Elliott is currently 46 years old. There are 5 older executives and no younger executives at Exact Sciences. The oldest executive at Exact Sciences is Mr. Kevin T. Conroy, Chairman of The Board & CEO, who is 58 years old. Learn More on Jeffrey Thomas Elliott's age.

What is Jeffrey Thomas Elliott's salary?

As the CFO of Exact Sciences Co., Mr. Elliott earns $518,130.00 per year. There are 3 executives that earn more than Mr. Elliott. The highest earning executive at Exact Sciences is Mr. Kevin T. Conroy, Chairman of The Board & CEO, who commands a salary of $1,540,000.00 per year. Learn More on Jeffrey Thomas Elliott's salary.

How do I contact Jeffrey Thomas Elliott?

The corporate mailing address for Mr. Elliott and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected]. Learn More on Jeffrey Thomas Elliott's contact information.

Has Jeffrey Thomas Elliott been buying or selling shares of Exact Sciences?

Jeffrey Thomas Elliott has not been actively trading shares of Exact Sciences during the last quarter. Most recently, Jeffrey Thomas Elliott sold 2,412 shares of the business's stock in a transaction on Friday, March 1st. The shares were sold at an average price of $59.32, for a transaction totalling $143,079.84. Following the completion of the sale, the chief financial officer now directly owns 10,933 shares of the company's stock, valued at $648,545.56. Learn More on Jeffrey Thomas Elliott's trading history.

Who are Exact Sciences' active insiders?

Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.

Are insiders buying or selling shares of Exact Sciences?

In the last twelve months, insiders at the medical research company sold shares 40 times. They sold a total of 137,948 shares worth more than $9,624,811.88. The most recent insider tranaction occured on April, 1st when EVP Sarah Condella sold 2,000 shares worth more than $140,000.00. Insiders at Exact Sciences own 1.3% of the company. Learn More about insider trades at Exact Sciences.

Information on this page was last updated on 4/1/2024.

Jeffrey Thomas Elliott Insider Trading History at Exact Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2024Sell2,412$59.32$143,079.8410,933View SEC Filing Icon  
2/27/2024Sell2,710$56.89$154,171.908,054View SEC Filing Icon  
2/21/2024Sell1,493$61.50$91,819.503,703View SEC Filing Icon  
2/15/2024Sell1,888$61.43$115,979.842,084View SEC Filing Icon  
8/21/2023Sell30,210$82.92$2,505,013.20View SEC Filing Icon  
2/28/2023Sell4,233$61.12$258,720.9629,241View SEC Filing Icon  
2/15/2023Sell1,866$65.59$122,390.9422,655View SEC Filing Icon  
2/13/2023Sell1,158$64.55$74,748.9020,549View SEC Filing Icon  
3/1/2022Sell4,050$76.69$310,594.50View SEC Filing Icon  
2/23/2022Sell1,557$69.05$107,510.85View SEC Filing Icon  
2/15/2022Sell1,839$79.55$146,292.45View SEC Filing Icon  
7/29/2021Sell38,361$111.40$4,273,415.40View SEC Filing Icon  
3/2/2021Sell4,230$139.24$588,985.2045,223View SEC Filing Icon  
2/24/2021Sell4,449$136.30$606,398.7049,613View SEC Filing Icon  
7/29/2020Sell8,746$95.58$835,942.6859,109View SEC Filing Icon  
2/27/2020Sell1,627$80.27$130,599.2957,743View SEC Filing Icon  
2/25/2020Sell4,910$85.11$417,890.1059,217View SEC Filing Icon  
7/30/2019Sell9,845$105.60$1,039,632.0041,012View SEC Filing Icon  
2/28/2019Sell2,447$93.20$228,060.40View SEC Filing Icon  
1/24/2019Sell90,909$78.90$7,172,720.10124,120View SEC Filing Icon  
7/30/2018Sell8,984$57.78$519,095.5222,690View SEC Filing Icon  
2/26/2018Sell2,982$42.34$126,257.88View SEC Filing Icon  
7/31/2017Sell5,846$39.41$230,390.8619,861View SEC Filing Icon  
See Full Table

Jeffrey Thomas Elliott Buying and Selling Activity at Exact Sciences

This chart shows Jeffrey Thomas Elliott's buying and selling at Exact Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exact Sciences Company Overview

Exact Sciences logo
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Read More

Today's Range

Now: $58.85
Low: $58.45
High: $60.31

50 Day Range

MA: $63.44
Low: $56.27
High: $74.26

2 Week Range

Now: $58.85
Low: $56.05
High: $100.77

Volume

2,018,885 shs

Average Volume

2,286,792 shs

Market Capitalization

$10.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25